Clinical trial
Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland (ESTIMATE): Evaluation of a Prediction Rule
NCT01277536 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland (ESTIMATE): Evaluation of a Prediction Rule
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- November 30, 2011
- Enrollment
- 1,478 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.